Ju Cynthia, Reilly Timothy P, Bourdi Mohammed, Radonovich Michael F, Brady John N, George John W, Pohl Lance R
Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA.
Chem Res Toxicol. 2002 Dec;15(12):1504-13. doi: 10.1021/tx0255976.
Hepatic injury induced by various toxic agents, including acetaminophen (APAP), has been attributed, in part, to the production of proinflammatory cytokines and other mediators by resident Kupffer cells within the liver. However, recent evidence from our laboratory has demonstrated that hepato-protective factors, such as interleukin (IL)-10 and cyclooxygenase-derived mediators, are also upregulated in response to hepatic damage to help protect against exacerbated injury, and Kupffer cells have been suggested to be a source of these modulatory factors. In other models, Kupffer cells also serve important regulatory functions in pathophysiological states of the liver. Therefore, we reevaluated the role of Kupffer cells in a murine model of APAP-induced liver injury using liposome-entrapped clodronate (liposome/clodronate) as an effective Kupffer cell-depleting agent. We show that in contrast to pretreatment of mice with a widely used macrophage inhibitor, gadolinium chloride, which did not deplete Kupffer cells but moderately protected against APAP-induced hepatotoxicity as reported previously, the intravenous injection of liposome/clodronate caused nearly complete elimination of Kupffer cells and significantly increased susceptibility to APAP-induced liver injury as compared with mice pretreated with empty liposomes. This increased susceptibility was apparently unrelated to the metabolism of APAP since liposome/clodronate pretreatment did not alter APAP-protein adduct levels. Instead, Kupffer cell depletion by liposome/clodronate led to significant decreases in the levels of hepatic mRNA expression of several hepato-regulatory cytokines and mediators, including IL-6, IL-10, IL-18 binding protein and complement 1q, suggesting that Kupffer cells are a significant source for production of these mediators in this model. Our findings indicate that, in addition to their protoxicant activities, Kupffer cells can also have an important protective function in the liver through the production of a variety of modulatory factors which may counteract inflammatory responses and/or stimulate liver regeneration.
包括对乙酰氨基酚(APAP)在内的各种毒性剂所诱导的肝损伤,部分归因于肝脏内常驻库普弗细胞产生促炎细胞因子和其他介质。然而,我们实验室最近的证据表明,肝保护因子,如白细胞介素(IL)-10和环氧化酶衍生介质,在肝脏损伤时也会上调,以帮助防止损伤加剧,并且有人提出库普弗细胞是这些调节因子的来源。在其他模型中,库普弗细胞在肝脏的病理生理状态中也发挥重要的调节功能。因此,我们使用脂质体包裹的氯膦酸盐(脂质体/氯膦酸盐)作为一种有效的库普弗细胞清除剂,重新评估了库普弗细胞在APAP诱导的小鼠肝损伤模型中的作用。我们发现,与用广泛使用的巨噬细胞抑制剂氯化钆预处理小鼠不同,氯化钆不会耗尽库普弗细胞,但如先前报道的那样能适度保护小鼠免受APAP诱导的肝毒性,静脉注射脂质体/氯膦酸盐导致库普弗细胞几乎完全清除,与用空脂质体预处理的小鼠相比,对APAP诱导的肝损伤的易感性显著增加。这种易感性增加显然与APAP的代谢无关,因为脂质体/氯膦酸盐预处理不会改变APAP-蛋白质加合物水平。相反,脂质体/氯膦酸盐导致的库普弗细胞耗竭导致几种肝脏调节细胞因子和介质的肝mRNA表达水平显著降低,包括IL-6、IL-10、IL-18结合蛋白和补体1q,这表明在该模型中库普弗细胞是这些介质产生的重要来源。我们的研究结果表明,除了其原毒性活性外,库普弗细胞还可以通过产生多种调节因子在肝脏中发挥重要的保护功能,这些调节因子可能抵消炎症反应和/或刺激肝脏再生。